DSIP

DSIP is a naturally occurring nonapeptide studied for sleep support, stress modulation, and slow-wave sleep enhancement.


Profile · 01

Overview

DSIP (Delta Sleep-Inducing Peptide) is a naturally occurring nonapeptide first isolated during sleep-related research and studied for slow-wave sleep support and stress modulation. It is not FDA-approved for any indication.

The literature discussed in the source includes preclinical and limited human work suggesting deeper delta-wave sleep without large REM disruption, along with HPA-axis and stress-response effects. This page presents that discussion as an educational once-daily bedtime protocol.

At a Glance

Goal
Support deeper restorative sleep and modulate stress-related signaling
Categories
Sleep SupportStress ModulationNeuromodulationRecovery
Synergistic
Melatonin · Magnesium glycinate · L-theanine · Glycine

Profile · 02

Protocol

Suggested bedtime titration approach starting low and increasing weekly.

Reconstitute
Add 3.0 mL bacteriostatic water to a 5 mg vial for about 1.67 mg/mL concentration
Typical daily range
100-300 mcg once daily before bed
Start
100 mcg nightly during Week 1
Target
250-300 mcg nightly by Weeks 4-8
Frequency
Once per day (subcutaneous), before bedtime
Cycle Length
4-8 weeks; optional extension to 12 weeks
Timing
Administer before bed and rotate injection sites
Route
Subcutaneous
Cycle
4-8 weeks on, 4 weeks off

Inject once daily subcutaneously before bedtime to match the peptide's sleep-oriented use case. The main table below reflects the standard gradual approach; the source also mentions more speculative advanced escalation beyond 300 mcg. Human data are limited, so minimum-effective-dose thinking is appropriate.

Dose progression

Week 1
100 mcg (0.1 mg) · 6 units (0.06 mL)
Week 2
150 mcg (0.15 mg) · 9 units (0.09 mL)
Week 3
200 mcg (0.2 mg) · 12 units (0.12 mL)
Weeks 4-8
250-300 mcg (0.25-0.3 mg) · 15-18 units (0.15-0.18 mL)

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Science · 01

How DSIP works.

DSIP was first characterized in sleep research and is discussed as a peptide that may enhance delta-wave sleep while leaving REM architecture relatively intact. Mechanistic discussion often includes GABAergic and opioid-system interactions as well as HPA-axis modulation.

Preclinical work and limited human studies support the idea of sleep normalization and stress-response moderation, but the total evidence base remains smaller and less definitive than the lore surrounding the peptide.


Science · 02

Effects

Observations from clinical or preclinical literature.

May support deeper slow-wave sleep and more restorative sleep architecture
May support stress modulation through HPA-axis and neuromodulatory pathways
Preclinical literature suggests low tolerance liability compared with some sedating drugs
Generally described as well tolerated in early research settings
Mild injection-site reactions such as redness or itching may occur
Long-term human safety and efficacy remain limited

Science · 03

Caution

Not recommended during pregnancy or breastfeeding because safety data is insufficient
Use caution with sedatives, sleep medications, or other CNS depressants when evaluating response
Use caution in endocrine disorders because the peptide is discussed in relation to HPA-axis signaling
Consult a qualified healthcare provider before use if you have chronic medical conditions or complex insomnia

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Lifestyle · 01

CoFactors

Magnesium glycinate
Supports relaxation and sleep quality through GABA-related pathways.
Zinc
Relevant to immune and neurotransmitter support.
Vitamin B6
Supports melatonin and serotonin synthesis.
Omega-3 fatty acids
Support neuronal membrane integrity and recovery.

Lifestyle · 02

Life Factors

Complementary strategies for best outcomes.

Maintain a consistent sleep-wake schedule to reinforce circadian rhythm
Limit blue-light exposure and late-day stimulants before bedtime
Use a cool, dark, quiet sleep environment to support deep sleep
Practice stress-management techniques to complement the peptide's intended use case

Lifestyle · 03

Metrics

Day-to-day metrics worth tracking through the protocol.

  1. Sleep quality and duration - track sleep onset, total time asleep, and morning restfulness
  2. Daytime energy and cognitive clarity - monitor whether better sleep is translating into better daytime function
  3. Stress and mood - watch for changes in subjective stress burden
  4. Injection-site reactions - note redness, swelling, or discomfort

Lifestyle · 04

Labs

Baseline and periodic bloodwork to monitor systemic health during the protocol.

Morning cortisol
Useful for tracking broader HPA-axis context.
CBC (Complete Blood Count)
General monitoring and baseline screening.
CMP (Comprehensive Metabolic Panel)
Assesses liver and kidney function during peptide use.
Thyroid panel
Helpful where sleep issues overlap with endocrine symptoms.

Calculators · 01

Supplies Calculator

Estimates assume the schedule defined for this peptide.

Length
Vial size
Bac. water
Syringe
Vials
0 × 5 mg each
Syringes
0
Bac. water
0 mL
Swabs
02 per syringe

Calculators · 02

Dose Calculator

Dose Calculator

Vial
Bac. water
Syringe
Dose
Concentration
0mcg/mL
Volume per dose
0mL

Practice · 01

Preparation

Careful technique preserves potency. Solution should be clear — do not shake.

  1. Allow vial to reach room temperature for 15–20 minutes before reconstitution.
  2. Draw the chosen bacteriostatic water volume with a sterile syringe.
  3. Inject slowly down vial wall; avoid foaming.
  4. Gently swirl/roll until dissolved (do not shake).
  5. Label with reconstitution date and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.
  6. Use within 30 days; discard any unused solution after 30 days.

Practice · 02

Technique

General subcutaneous guidance from clinical best-practice resources.

Clean the vial stopper and injection site with alcohol and allow them to dry
Pinch a skinfold and insert the needle at 45-90 degrees into subcutaneous tissue
Do not aspirate for subcutaneous injections; inject slowly and steadily
Rotate sites systematically across the abdomen, thighs, and upper arms
Discard used syringes immediately in a sharps container

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.


Practice · 03

Storage

Lyophilized
Store at room temp in dry, dark conditions; minimize moisture exposure.
Reconstituted
Refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles. Discard reconstituted vials after 30 days.

Notes

Allow vials to reach room temperature before opening to reduce condensation uptake.

Reference · 01

Notes

Use a new sterile insulin syringe for each injection and dispose of it safely
Lower starting volumes may be easier to read on 30-unit or 50-unit syringes
The source mentions advanced dosing beyond 300 mcg, but that is less supported than the standard table
Minimum effective dose is a sensible default because human evidence remains limited
PepTribe is an educational platform. This information is for research and learning purposes only and is not medical advice.

Reference · 02

References

  1. PNAS (1977)
    Original characterization of delta sleep-inducing peptide.
    https://pubmed.ncbi.nlm.nih.gov/16592440/
  2. Neuropsychobiology
    Early human work on DSIP psychophysiologic properties.
    https://pubmed.ncbi.nlm.nih.gov/6633115/
  3. Annals of the New York Academy of Sciences
    Stress-protective discussion of DSIP sequelae.
    https://pubmed.ncbi.nlm.nih.gov/15677401/
  4. Neuroscience and Biobehavioral Reviews
    Classic DSIP review literature.
    https://pubmed.ncbi.nlm.nih.gov/6392951/
  5. NCBI Bookshelf
    General subcutaneous-injection best-practice guidance.
    https://www.ncbi.nlm.nih.gov/books/NBK596739/
On this page